David D. Davidar, Director at GLOBUS MEDICAL INC (GMED), sold 20,000 shares at $65.00 ($1.3M) on 2024-05-08, disclosed to the SEC on 2024-05-10.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GMED | SELL | 2024-11-25 | $3.4M | — | Filing → |
| GMED | SELL | 2024-10-18 | $3.8M | — | Filing → |
| GMED | SELL | 2024-09-17 | $3.5M | — | Filing → |